BioCentury
ARTICLE | Company News

Acambis, Flanders Interuniversity for Biotechnology deal

August 8, 2005 7:00 AM UTC

The parties partnered to develop a vaccine against influenza A and B that is based on M2e and will not require annual changes to the formulation. M2e is the extracellular domain of the ion channel pro...